2015
DOI: 10.1002/ppul.23261
|View full text |Cite
|
Sign up to set email alerts
|

An effective combination of sanger and next generation sequencing in diagnostics of primary ciliary dyskinesia

Abstract: We present a combination of Sanger sequencing with an NGS panel for known and candidate PCD genes, implemented in a moderate-size national collection of patients. This strategy has proven to be cost-effective, rapid and reliable, and was able to detect the causative gene in two thirds of our PCD patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
19
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(25 citation statements)
references
References 39 publications
4
19
0
2
Order By: Relevance
“…This was equivalent between patients with and without situs inversus and without any prior TEM, HSVM or nitric oxide screening; however, this cohort largely displays severe respiratory symptoms suggestive for PCD. This yield is comparable to the output of other studies, where causative mutations could be identified in 70 to 80% of PCD patients . Genetic testing has therefore proved to be a highly successful single test for PCD diagnosis in Egypt.…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…This was equivalent between patients with and without situs inversus and without any prior TEM, HSVM or nitric oxide screening; however, this cohort largely displays severe respiratory symptoms suggestive for PCD. This yield is comparable to the output of other studies, where causative mutations could be identified in 70 to 80% of PCD patients . Genetic testing has therefore proved to be a highly successful single test for PCD diagnosis in Egypt.…”
Section: Discussionsupporting
confidence: 70%
“…This yield is comparable to the output of other studies, where causative mutations could be identified in 70 to 80% of PCD patients. [22][23][24][25] Genetic testing has therefore proved to be a highly successful single test for PCD diagnosis in Egypt.…”
Section: Discussionmentioning
confidence: 99%
“…The extensive genetic heterogeneity in PCD makes NGS approaches also attractive for use in the diagnostic setting, as it offers parallel sequencing of multiple genes or of the entire exome. The diagnostic yield of targeted NGS panels used in Europe and the United States currently varies between 43% and 76% (Boaretto et al., ; Djakow et al., ; Marshall et al., ). This means that genetic testing cannot yet provide enough certainty to be used as the sole test for PCD.…”
Section: Introductionmentioning
confidence: 99%
“…Investigators from the Czech Republic reported on a method utilizing an initial step of Sanger sequencing a small panel of genes for variants commonly found in the Czech population, followed by screening of a broader panel employing next-generation sequencing (NGS). 63 This approach provided timely, accurate, and cost-effective results, and identified a causative variant in two-thirds of tested patients. This may serve as a model for developing similar approaches, accounting for known population prevalence.…”
Section: Consensus Panel Recommendations and Expert Opinion Is Criticmentioning
confidence: 99%
“…Given the amount of genetic heterogeneity, testing for genetic causes of PCD has proven to be challenging. Investigators from the Czech Republic reported on a method utilizing an initial step of Sanger sequencing a small panel of genes for variants commonly found in the Czech population, followed by screening of a broader panel employing next‐generation sequencing (NGS) . This approach provided timely, accurate, and cost‐effective results, and identified a causative variant in two‐thirds of tested patients.…”
Section: Rare Lung Diseasementioning
confidence: 99%